<qa>  What is the name of the immunomodulatory drug that must have been used in patients with multiple2. Patients with multiple myeloma,relapsed or refractory after failure of two or more lines of systemic treatments. All patients must have received at least one immunomodulatory drug IMiD and a proteasome inhibitor. 